Search results

Skip to results

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Your search for Delph returned no results
Showing 1 to 15 of 18 results for delphi

  1. Voxelotor for treating haemolytic anaemia caused by sickle cell disease (TA981)

    Evidence-based recommendations on voxelotor (Oxbryta) for haemolytic anaemia caused by sickle cell disease in people 12 years and over.

  2. Romosozumab for treating severe osteoporosis (TA791)

    Evidence-based recommendations on romosozumab (EVENITY) for severe osteoporosis in people after menopause who are at high risk of fracture.

  3. Andexanet alfa for reversing anticoagulation from apixaban or rivaroxaban (TA697)

    Evidence-based recommendations on andexanet alfa (Ondexxya) for reversing anticoagulation form apixaban or rivaroxaban in adults with life-threatening or uncontrolled bleeding.

  4. Cannabidiol for treating seizures caused by tuberous sclerosis complex (TA873)

    Evidence-based recommendations on cannabidiol (Epidyolex) for treating seizures caused by tuberous sclerosis complex.

  5. Evidence standards framework (ESF) for digital health technologies

    NICE standards for innovators of digital health technologies and NHS commissioners

  6. Standards framework for shared-decision-making support tools, including patient decision aids (ECD8)

    This framework sets out a series of standards to support people using patient decision aids (PDAs) in assessing the usefulness and quality of a PDA

  7. Dyspepsia and gastro‑oesophageal reflux disease in adults (QS96)

    This quality standard covers investigating and managing symptoms of dyspepsia (indigestion) and gastro-oesophageal reflux disease (heartburn or reflux) in adults (aged 18 and over). It describes high-quality care in priority areas for improvement.

  8. Consensus based national antimicrobial stewardship competencies for UK undergraduate healthcare professional education

    developed through a commonly used formal consensus method, i.e. a modified Delphi technique. This technique used two on-line survey...

  9. Mexiletine for treating the symptoms of myotonia in non-dystrophic myotonic disorders (TA748)

    Evidence-based recommendations on mexiletine (Namuscla) for treating the symptoms of myotonia in adults with non-dystrophic myotonic disorders.

  10. Darvadstrocel for treating complex perianal fistulas in Crohn's disease (TA556)

    Evidence-based recommendations on darvadstrocel (Alofisel) for previously treated complex perianal fistulas in adults with non-active or mildly active luminal Crohn’s disease.

  11. Healthy.io test for home testing of urine albumin to creatinine ratio (MIB221)

    NICE has developed a medtech innovation briefing (MIB) on Healthy.io test for home testing of urine albumin to creatinine ratio .

  12. User guide for the cost comparison company evidence submission template (PMG32)

    User guide for the cost comparison company evidence submission template

  13. Degarelix for treating advanced hormone-dependent prostate cancer (TA404)

    Evidence-based recommendations on degarelix (Firmagon) for advanced hormone-dependent prostate cancer in adults with spinal metastases.

  14. Interim methods guide for developing good practice guidance (PMG15)

    Interim methods guide for developing good practice guidance

  15. Single technology appraisal and highly specialised technologies evaluation: User guide for company evidence submission template (PMG24)

    Single technology appraisal and highly specialised technologies evaluation: User guide for company evidence submission template